Sequential HAART in treatment resistant HIV-1 infected patients/
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Antiretrovirals
- Indications HIV-1 infections
- Focus Therapeutic Use
- 22 Sep 2009 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 22 Sep 2009 Actual patient number (3) added as reported by ClinicalTrials.gov.
- 22 Sep 2009 Planned end date (Jan 2007) added as reported by ClinicalTrials.gov.